Skip to main content
SpringerLink
Log in

Long-term effects of ACE inhibitor on vascular remodelling

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

The long-term pathomorphological changes of the injured vessels under angiotensin-converting-enzyme (ACE) inhibitor are still not known. Therefore, we assessed the alternations of vascular architecture after three-month therapy with ACE inhibitor and identified new target cells for this medication. Carotid arteries of spontaneously hypertensive rats underwent balloon angioplasty. 14 days prior intervention, half of the animals was treated with ACE inhibitor. After three months of vascular trauma, the injured vessels were explored by histomorphology and immunohistochemistry for angiotensin-II receptor (AT1R), dendritic and HSP47+ cells. The neointimal growth decreased significantly only up to 28 days under ACE inhibitor. In contrast, the reductive effect of ACE inhibitor on media area persisted up to three months after intervention. A significant fraction of early neointimal cells was of a dendritic cell type. The relevant portion of these cells showed an expression of AT1R and HSP47. AT1R was present in 70% and HSP47 in 18% of all early neointimal cells in both groups. ACE inhibitor may at least temporarily diminish remodelling processes in injured vessels. The detection of AT1R on dendritic cells identifies these cells as important targets for therapeutic strategies involving modulation of the renin-angiotensin system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eltchaninoff H., Koning R., Christphe T., Gupta V., Cribier A., Balloon Angioplasty for the treatment of Coronary In-Stent Restensosis: Immediate Results and 6-Month Angiographic Recurrent Restenosis Rate, J. Am. Coll. Cardiol., 1998, 32, 980–984

    Article  CAS  PubMed  Google Scholar 

  2. Tsang J., Sheppard R., Hou Mak K., Brown D., Huynh T., Schechter D., et al., Six-month outcomes of percutaneous transluminal coronary angioplasty in hypertensive patients: Results from the ROSETTA registry, Am. Heart. J., 2002, 1, 124–129

    Article  Google Scholar 

  3. Cutlip D.E., Chauhan M.S., Baim D.S., Ho K.K.L., Poppma J.J., Carrozza J.P., et al., Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials, J. Am. Coll. Cardiol., 2002, 40, 2082–2089

    Article  PubMed  Google Scholar 

  4. Mehta P.K., Griendling K.K., Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am. J. Physiol. Cell. Physiol., 2007, 292, C82–97

    CAS  PubMed  Google Scholar 

  5. Kleinert S., HOPE for cardiovascular disease prevention with ramipril, Lancet, 1999, 354, 841

    Article  CAS  PubMed  Google Scholar 

  6. Tropeano A.I., Saleh N., Hawajri N., Macquin-Mavier I., Maison P., Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials, Fundam. Clin. Pharmacol., 2011, 25, 395–404

    Article  CAS  PubMed  Google Scholar 

  7. Hanson S.R., Powell J.S., Dodson T., Lumsden A., Kelly A.B., Anderson J.S., et al., Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon, Hypertension, 1991, 18, II70–76

    Article  CAS  PubMed  Google Scholar 

  8. Phillips M.I., Kagiyama S., Angiotensin II as a proinflammatory mediator, Curr. Opin. Investig. Drugs, 2002, 3, 569–577

    CAS  PubMed  Google Scholar 

  9. Skowasch D., Jabs A., Andrié R., Dinkelbach S., Schiele TM., Wernert N., et al., Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis, J. Vasc. Res., 2004, 41, 525–534

    Article  PubMed  Google Scholar 

  10. Tuleta I., Skowasch D., Peuster M., Nickenig G., Bauriedel G., Cells of primarily extravascular origin in neointima formation following stent implantation: coordinated expression of endothelial progenitor, dendritic and neural crest-derived cells, Cardiology, 2008, 110, 199–205

    Article  PubMed  Google Scholar 

  11. Jandeleit-Dahm K., Burrell L.M., Johnston C.I., Koch K.M., Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats, J. Hypertens., 1997, 15, 643–650

    Article  CAS  PubMed  Google Scholar 

  12. Clozel J.P., Müller R.K., Roux S., Fischli W., Baumgartner HR., Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats, Circulation, 1993, 88, 1222–1227

    Article  CAS  PubMed  Google Scholar 

  13. Schmitt R., Clozel J.P., Iberg N., Bühler FR., Prevention of neointima formation by mibefradil after vascular injury in rats: comparison with ACE inhibition, Cardiovasc. Drugs Ther., 1996, 10, 101–105

    Article  CAS  PubMed  Google Scholar 

  14. Hannan J.L., Blaser M.C., Pang J.J., Adams S.M., Pang S.C., Adams M.A., Impact of hypertension, aging, and antihypertensive treatment on the morphology of the pudendal artery, J. Sex. Med., 2011, 8, 1027–1038

    Article  CAS  PubMed  Google Scholar 

  15. Hong Y.J., Jeong M.H., Song S.J., Sim D.S., Kim J.H., Lim K.S., et al., Effects of ramiprilat-coated stents on neointimal hyperplasia, inflammation, and arterial healing in a porcine coronary restenosis model, Korean Circ. J., 2011, 41, 535–541

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Tyralla K., Adamczak M., Benz K., Campean V., Gross M.L., Hilgers K.F., et al., High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy, PLoS One, 2011, 6, e15287

    Article  PubMed Central  PubMed  Google Scholar 

  17. Yilmaz R., Altun B., Kahraman S., Ozer N., Akinci D., Turgan C., Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intimamedia thickness in nondiabetic hemodialysis patients, Ren. Fail., 2010, 32, 903–912

    Article  CAS  PubMed  Google Scholar 

  18. Matsuno H., Stassen J.M., Moons L., Vermylen J., Hoylaerts M.F., Neointima formation in injured hamster carotid artery is effectively prevented by the combination G4120 and quinapril, Thromb. Haemost., 1996, 76, 263–269

    CAS  PubMed  Google Scholar 

  19. Kalinowski M., Tepe G., Schieber A., Brehme U., Bruck B., Erley C.M., et al., Local administration of ramiprilat is less effective than oral ramipril in preventing restenosis after balloon angioplasty in an animal model, J. Vasc. Interv. Radiol., 1999, 10, 1397–1404

    Article  CAS  PubMed  Google Scholar 

  20. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial, Circulation, 1992, 86, 100–110

    Google Scholar 

  21. Desmet W., Vrolix M., De Scheerder I., Van Lierde J., Willems J.L., Piessens J., Angiotensinconverting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty, Circulation, 1994, 89, 385–392

    Article  CAS  PubMed  Google Scholar 

  22. Fukuda D., Enomoto S., Nagai R., Sata M., Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation, Biomed. Pharmacother., 2009, 63, 754–761

    Article  CAS  PubMed  Google Scholar 

  23. Śladowska-Kozłowska J., Litwin M., Niemirska A., Płudowski P., Wierzbicka A., Skorupa E., et al., Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy, Pediatr. Nephrol., 2012, 27, 1943–1951

    Article  PubMed Central  PubMed  Google Scholar 

  24. Zhong J.C., Ye J.Y., Jin H.Y., Yu X., Yu H.M., Zhu D.L., et al., Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression, Regul. Pept., 2011, 166, 90–97

    Article  CAS  PubMed  Google Scholar 

  25. Wong J., Rauhöft C., Dilley R.J., Agrotis A., Jennings G.L., Bobik A., Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation, Circulation, 1997, 96, 1631–1640

    Article  CAS  PubMed  Google Scholar 

  26. Hernández-Presa M.A., Bustos C., Ortego M., Tuñón J., Ortega L., Egido J., ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis, Am. J. Pathol., 1998, 153, 1825–1837

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II - Cardiology and Pulmonology, University of Bonn, Bonn, Germany

    Izabela Tuleta, Gerhard Bauriedel, Stefan Krämer, Georg Nickenig & Dirk Skowasch

Authors
  1. Izabela Tuleta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerhard Bauriedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Krämer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georg Nickenig
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dirk Skowasch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Izabela Tuleta.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuleta, I., Bauriedel, G., Krämer, S. et al. Long-term effects of ACE inhibitor on vascular remodelling. cent.eur.j.med 9, 741–747 (2014). https://doi.org/10.2478/s11536-013-0343-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0343-6

Keywords

Search

Navigation